FMP
Heart Test Laboratories, Inc.
HSCS
NASDAQ
Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.
2.94 USD
-0.21 (-7.14%)
About
ceo
Mr. Andrew Simpson
sector
Healthcare
industry
Medical - Devices
website
https://heartsciences.comexchange
NASDAQ
Description
Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.
CIK
0001468492
ISIN
US42254E1047
CUSIP
42254E104
Address
550 Reserve Street
Phone
682 237 7781
Country
US
Employee
15
IPO Date
Jun 16, 2022
Key Executives
